Cases 1 - 10 of 13
Bayer Pharma AG et al v. Cipla Ltd. et al
as 1:2023cv01196
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Cipla Ltd., Cipla USA Inc. and Invagen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. v. InvaGen Pharmaceuticals, Inc.
as 1:2019cv01496
Defendant:
InvaGen Pharmaceuticals, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
as 1:2019cv00219
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. InvaGen Pharmaceuticals, Inc.
as 1:2018cv01788
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca LP et al v. InvaGen Pharmaceuticals Inc.
as 1:2017cv01073
Plaintiff:
AstraZeneca LP , AstraZeneca AB , AstraZeneca UK Limited and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 145
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00812
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00377
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc.
as 1:2017cv00374
Defendant:
Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Lupin Atlantis Holdings S.A. v. InvaGen Pharmaceuticals Inc.
as 1:2016cv00708
Plaintiff:
Lupin Atlantis Holdings S.A.
Defendant:
InvaGen Pharmaceuticals Inc.
Counter_claimant:
InvaGen Pharmaceuticals Inc.
Counter_defendant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2016cv00064
Plaintiff:
Bayer Intellectual Property GmbH , Bayer Pharma AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
